Open Access Government produces compelling and informative news, publications, eBooks, and academic research articles for the public and private sector looking at health, diseases & conditions, workplace, research & innovation, digital transformation, government policy, environment, agriculture, energy, transport and more.
Home Search
diabetes care - search results
If you're not happy with the results, please do another search
The impact of digital care platforms on healthcare professionals and patients
Dr Simon Bourne, founder and CEO of my mhealth and former COPD lead at Southampton University, examines the digital goals outlined in the NHS long-term plan and the impact of digital patient care platforms on healthcare professionals (HCPs) and patients.
COVID-19 and diabetes telehealth
Cecilia Van Cauwenberghe from Frost & Sullivan’s TechCasting Group, explains how the COVID-19 pandemic is the scenario for testing and demonstrating the successful implementation of diabetes telehealth platforms.
Is the UK heading for a “perfect storm” of diabetes referrals?
Here, a leading clinical negligence specialist warns the UK may be heading for a “perfect storm” of diabetes complications, due to delayed COVID-19 referrals.
People with obesity nearly three times as likely to get Type 2 diabetes
New research by the American Heart Association finds that obesity is a factor in almost half of all new cases, with obese individuals significantly more likely to get Type 2 diabetes.
Exercise during the first trimester may reduce gestational diabetes risk
According to a new study, pregnant women who exercise more during the first trimester may have a lower risk of developing gestational diabetes.
Veganism and women’s healthcare: Contraceptive options for vegans
Dr Deborah Lee, Dr Fox Online Pharmacy, considers the contraceptive options available for vegans and the benefits and risks it can have on women's health.
Olivia Burr – Diabetes UK
Olivia is a registered nurse and public health practitioner passionate about improvement, involvement, and tackling inequalities. She is currently the Inpatient Care Lead at Diabetes UK.
Diabetes: How can we improve patient wellbeing & national health outcomes?
Claus Møldrup, DrugsDisclosed.com Founder and Former Professor in Social Pharmacy at the University of Copenhagen, turns the spotlight on diabetes and explores how to improve patient wellbeing and national health outcomes.
Diabetes patients are three times as likely to have severe COVID
While diabetes has been declared as a signifier for infection complications, researchers now say that data suggests it is three times as likely these individuals have severe COVID or are hospitalised.
Why a reformed social care system in the UK cannot wait
Fiona Carragher, Director of Research and Influencing at Alzheimer’s Society walks us through why a reformed social care system in the UK cannot wait.
Diabetes increases risk of COVID-19 brain complications
New research finds that bleeding and stroke are COVID-19 brain complications that are more frequent in people with diabetes and hypertension.
The future of treating gestational diabetes
Dr Lucy Mackillop, Chief Medical Officer, Sensyne Health discusses the future of treating gestational diabetes.
AI technology can help diagnose birth defects and gestational diabetes
Researchers from the University of Seville have found that artificial intelligence (AI) can help to diagnose birth defects, gestational diabetes and preterm birth earlier.
Bridging the gap between clinical trials and clinical care
Here, Tatiana Affini Dicenzo and Freimut Schliess discuss bridging the gap between clinical trials and clinical care, specifically exploring if wearables are fit for this purpose.
COVID-19 and diabetes: What do we (not) know?
Dr Lucy Chambers, Head of Research Communications at Diabetes UK, provides us with her thoughts on COVID-19 and diabetes, in terms of what do we (not) know.
Rethinking Type 1 diabetes with a radically new immunotherapy approach
Jean Van Rampelbergh PhD, VP Clinical & Regulatory at Imcyse SA, introduces Imotopes™, the innovative new immunotherapy approach causing scientists to rethink Type 1 diabetes and its treatment.
Digital twins – are they game-changers in clinical research and clinical care?
Prof Dr Freimut Schliess, Director of Science & Innovation at the Profil Institut für Stoffwechselforschung GmbH, explores if digital twins are game-changers in clinical research and clinical care.
Importance of choice: Insulin delivery systems for Type 1 diabetes in the UK (Advertorial)
Hjalte Hojsgaard, Insulet International, highlights why choice of insulin delivery devices is important, and why access to this life-changing technology is not yet fully utilised in UK diabetes services.
Diabetes: Innovative technology for long-term health conditions
Here, we discover why Gendius’ remote management technology, Intellin®, is poised to transform the way that we manage long-term health conditions including diabetes.
The relationship between diabetes and muscle mass
InBody Clinical Team describes the relationship between diabetes, one of the most common diseases of the modern age, and muscle mass.
